Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Basic and Clinical Physiology and Pharmacology

Editor-in-Chief: Horowitz, Michal

Editorial Board: Das, Kusal K. / Epstein, Yoram / S. Gershon MD, Elliot / Haim, Abraham / Kodesh , Einat / Kohen, Ron / Lichtstein, David / Maloyan, Alina / Mechoulam, Raphael / Roth, Joachim / Schneider, Suzanne / Shohami, Esther / Sohmer, Haim / Yoshikawa, Toshikazu

6 Issues per year


CiteScore 2016: 1.01

SCImago Journal Rank (SJR) 2016: 0.349
Source Normalized Impact per Paper (SNIP) 2016: 0.495

Online
ISSN
2191-0286
See all formats and pricing
More options …
Volume 25, Issue 2

Issues

Cerebral stroke injury: the role of cytokines and brain inflammation

Antonio Siniscalchi / Luca Gallelli / Giovanni Malferrari / Domenico Pirritano / Raffaele Serra
  • Department of Medical and Surgical Science, School of Medicine, University of Catanzaro, Catanzaro, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ermenegildo Santangelo / Giovambattista De Sarro
Published Online: 2014-02-07 | DOI: https://doi.org/10.1515/jbcpp-2013-0121

Abstract

Stroke represents the most frequent cause of permanent disability in adults worldwide. Cerebral ischemia triggers the pathological pathways of the ischemic cascade and causes irreversible neuronal injury in the ischemic core within minutes of the onset. Elements of the immune system are involved in all stages of ischemic cascade from acute intravascular events triggered by the interruption of blood supply, to the parenchymal processes leading to brain damage and to the ensuing tissue repair. In this review, we will provide a brief overview of current understanding of the role of cytokines and brain inflammation during acute ischemic stroke.

Keywords: cerebral ischemia; immune system; inflammation

References

  • 1.

    Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4: 399–415.PubMedCrossrefGoogle Scholar

  • 2.

    Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology 2013;80:S5–12.CrossrefPubMedGoogle Scholar

  • 3.

    Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612–23.Google Scholar

  • 4.

    Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009;7:97.PubMedCrossrefGoogle Scholar

  • 5.

    Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007;20:334–42.CrossrefPubMedGoogle Scholar

  • 6.

    Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391–7.PubMedCrossrefGoogle Scholar

  • 7.

    Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006;37:291–3.CrossrefPubMedGoogle Scholar

  • 8.

    Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011;17:796–808.PubMedCrossrefGoogle Scholar

  • 9.

    Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010;67:181–98.PubMedCrossrefGoogle Scholar

  • 10.

    Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734–44.CrossrefPubMedGoogle Scholar

  • 11.

    Urra X, Cerveraa A, Villamor N, Planas AM, Chamorro A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 2009;158:1174–83.Google Scholar

  • 12.

    Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139–45.Google Scholar

  • 13.

    Gallelli L, Busceti MT, Vatrella A, Maselli R, Pelaia G. Update on anticytokine treatment for asthma. Biomed Res Int 2013;2013:104315.PubMedGoogle Scholar

  • 14.

    Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer’s disease, role of cytokines. Sci World J 2012;2012:756357.Google Scholar

  • 15.

    Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol 2010;28:321–42.PubMedCrossrefGoogle Scholar

  • 16.

    Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C, et al. Transforming growth factor-β 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 2002;22:3898–909.Google Scholar

  • 17.

    Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998;251: 189–92.Google Scholar

  • 18.

    Banwell V, Sena ES, Macleod MR. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis 2009;18:269–76.Google Scholar

  • 19.

    Elkind MS. Impact of innate inflammation in population studies. Ann NY Acad Sci 2010;1207:97–106.Google Scholar

  • 20.

    Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006;26:654–65.Google Scholar

  • 21.

    Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012;32:1677–98.Google Scholar

  • 22.

    Murray KN, Buggey HF, Denes A, Allan SM. Systemic immune activation shapes stroke outcome. Mol Cell Neurosci 2013;53:14–25.CrossrefPubMedGoogle Scholar

  • 23.

    Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Gallai V. Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol 2004;11:377–81.PubMedCrossrefGoogle Scholar

  • 24.

    Yan J, Greer JM, McCombe PA. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J Neuroimmunol 2012;246:78–84.Google Scholar

  • 25.

    Zeng L, Wang Y, Liu J, Wang L, Weng S, Chen K, et al. Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci Lett 2013;548:4–9.Google Scholar

  • 26.

    Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 2012;26:1051–70.Google Scholar

  • 27.

    Caso JR, Moro MA, Lorenzo P, Lizasoain I, Leza JC. Involvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in rats. Eur Neuropsychopharm 2007;17:600–7.Google Scholar

  • 28.

    Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1α and IL-1β in ischemic brain damage. J Neurosci 2001;21:5528–34.Google Scholar

  • 29.

    Deroide N, Li X, Lerouet D, Van Vre E, Baker L, Harrison J, et al. MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injury. J Clin Invest 2013;123: 1176–81.Google Scholar

  • 30.

    Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F. Time course of IL-6 expression in experimental CNS ischemia. Neurol Res 1999;21:287–92.PubMedGoogle Scholar

  • 31.

    Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003;34:1864–9.PubMedCrossrefGoogle Scholar

  • 32.

    Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325–9.PubMedCrossrefGoogle Scholar

  • 33.

    Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000;31:1715–20.PubMedCrossrefGoogle Scholar

  • 34.

    Chen WY, Chang MS. IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke. J Immunol 2009;182:5003–12.CrossrefPubMedGoogle Scholar

  • 35.

    Smith CJ, Emsley HC, Udeh CT, Vail A, Hoadley ME, Rothwell NJ, et al. Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression. Cytokine 2012;58:384–9.Google Scholar

  • 36.

    Gueorguieva I, Clark SR, McMahon CJ, Scarth S, Rothwell NJ, Tyrell PJ, et al. Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage. Br J Clin Pharmacol 2008;65:317–25.Google Scholar

  • 37.

    Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 2013;28:375–86.PubMedCrossrefGoogle Scholar

  • 38.

    Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997;110:492–9.CrossrefPubMedGoogle Scholar

  • 39.

    da Cunha AA, Ferreira AG, Loureiro SO, da Cunha MJ, Schmitz F, Netto CA, et al. Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 2012;37:1660–9.PubMedCrossrefGoogle Scholar

  • 40.

    Siniscalchi A. Hyperhomocysteinemia in neurologic diseases. Recenti Prog Med 2004;95:371–5; quiz 402.Google Scholar

  • 41.

    Siniscalchi A, De Sarro G, Loizzo S, Gallelli L. High plasma homocysteine and low serum folate levels induced by antiepileptic drugs in Down Syndrome. J Dev Disabil 2012;18:70–6.Google Scholar

  • 42.

    Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G. Role of lifestyle factors on plasma homocysteine levels in Parkison’s disease patients treated with levodopa. Nutr Neurosci 2006;9:11–6.CrossrefGoogle Scholar

  • 43.

    Siniscalchi A, Mancuso F, Gallelli L, Ibbadu GF, Mercuri NB, De Sarro G. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res 2005;52:367–75.CrossrefPubMedGoogle Scholar

  • 44.

    Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78:539–52.PubMedCrossrefGoogle Scholar

  • 45.

    Iversen PO, Nicolaysen A, Kvernebo K, Benestad HB, Nicolaysen G. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch 1999;439:93–100.Google Scholar

  • 46.

    Vila E, Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005;288:H1016–21.PubMedGoogle Scholar

  • 47.

    Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002;8:1363–8.CrossrefPubMedGoogle Scholar

  • 48.

    Song W, Huo T, Guo F, Wang H, Wei H, Yang Q, et al. Globular adiponectin elicits neuroprotection by inhibiting NADPH oxidase-mediated oxidative damage in ischemic stroke. Neuroscience 2013;248C:136–44.Google Scholar

  • 49.

    Pham LD, Hayakawa K, Seo JH, Nguyen MN, Som AT, Lee BJ, et al. Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 2012;60:875–81.PubMedCrossrefGoogle Scholar

  • 50.

    de Franciscis S, Mastroroberto P, Gallelli L, Buffone G, Montemurro R, Serra R. Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm. Ann Vasc Surg 2013;27:1185 e5–7.Google Scholar

  • 51.

    de Franciscis S, Gallelli L, Battaglia L, Molinari V, Montemurro R, Stillitano DM, et al. Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease. Int Wound J 2013; Epub ahead of print 15 May 2013. DOI: 10.1111/iwj.12085.CrossrefGoogle Scholar

  • 52.

    Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L, et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013;21:395–401.CrossrefGoogle Scholar

  • 53.

    Serra R, Gallelli L, Buffone G, Molinari V, Stillitano DM, Palmieri C, et al. Doxycycline speeds up healing of chronic venous ulcers. Int Wound J 2013; Epub ahead of print 5 Apr 2013. DOI: 10.1111/iwj.12077.CrossrefGoogle Scholar

  • 54.

    Liu H, Wei X, Chen L, Liu X, Li S, Zhang X. Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion injury in the rat by an antioxidant action via inhibition of NADPH oxidase and iNOS expression. Pharmacology 2013;92:198–206.Google Scholar

  • 55.

    Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009;158:1098–111.Google Scholar

  • 56.

    Chapman KZ, Dale VQ, Denes A, Bennett G, Rothwell NJ, Allan SM, et al. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 2009;29:1764–8.Google Scholar

  • 57.

    Chang L, Chen Y, Li J, Liu Z, Wang Z, Chen J, et al. Cocaine- and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Brain Behav Immun 2011;25:260–9.PubMedCrossrefGoogle Scholar

  • 58.

    Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol 2012;69:576–81.PubMedGoogle Scholar

  • 59.

    Sanchez-Mendoza E, Bellver V, Merino JJ, Gonzalez M, Martinez-Murillo R, Oset-Gasque MJ. Review: could neurotransmitters influence neurogenesis and neurorepair after stroke? Neuropathol Appl Neurobiol 2013; Epub ahead of print 14 Aug 2013. DOI: 10.1111/nan.12082.CrossrefGoogle Scholar

  • 60.

    Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 2011;42:2645–50.PubMedCrossrefGoogle Scholar

  • 61.

    Tiebosch IA, Crielaard BJ, Bouts MJ, Zwartbol R, Salas-Perdomo A, Lammers T, et al. Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats. J Neurochem 2012;123:65–74.PubMedCrossrefGoogle Scholar

  • 62.

    Rodriguez-Yanez M, Castellanos M, Sobrino T, Brea D, Ramos-Cabrer P, Pedraza S, et al. Interleukin-10 facilitates the selection of patients for systemic thrombolysis. BMC Neurol 2013;13:62.CrossrefGoogle Scholar

About the article

Corresponding author: Luca Gallelli, Chair of Pharmacology, Department of Health Science, School of Medicine, University of Catanzaro, Clinical Pharmacology Unit, Mater Domini University Hospital, Viale Europa, Germaneto, 88100 Catanzaro, Italy, Phone: +39-0961-712322, Fax: +39-0961-774424, E-mail:

aAntonio Siniscalchi and Luca Gallelli contributed equally to this work.


Received: 2013-08-13

Accepted: 2014-01-10

Published Online: 2014-02-07

Published in Print: 2014-05-01


Citation Information: Journal of Basic and Clinical Physiology and Pharmacology, Volume 25, Issue 2, Pages 131–137, ISSN (Online) 2191-0286, ISSN (Print) 0792-6855, DOI: https://doi.org/10.1515/jbcpp-2013-0121.

Export Citation

©2014 by Walter de Gruyter Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Anna Bajnok, László Berta, Csaba Orbán, Tivadar Tulassay, and Gergely Toldi
Journal of Neuroinflammation, 2018, Volume 15, Number 1
[2]
Zeinab Adel Samy, Lulwa Al-Abdullah, Marian Turcani, James Craik, and Zoran Redzic
Brain and Behavior, 2018, Page e01013
[3]
Maria Fe Lanfranco, Italo Mocchetti, Mark P. Burns, and Sonia Villapol
Frontiers in Neuroanatomy, 2018, Volume 11
[4]
Weixin Zhu, Weihong Qiu, and Ailan Lu
Molecular Medicine Reports, 2017, Volume 16, Number 6, Page 9361
[5]
Dong-Ju Park, Myeong-Ok Kim, and Phil-Ok Koh
Laboratory Animal Research, 2017, Volume 33, Number 3, Page 202
[6]
Yiling Fan, Shenghao Ding, Yameng Sun, Bing Zhao, Yaohua Pan, and Jieqing Wan
Journal of Cellular Biochemistry, 2017
[7]
Xiang Zhou, Yong Liu, Yang Huang, ShuiBo Zhu, Jian Zhu, and RongPing Wang
Scientific Reports, 2017, Volume 7, Number 1
[8]
Zeng-Feng Su, Zhong-Wu Sun, Ying Zhang, Shu Wang, Qi-Gui Yu, and Ze-Bing Wu
The Kaohsiung Journal of Medical Sciences, 2017, Volume 33, Number 8, Page 369
[9]
Jonathan A. Micieli, Cindy Lam, Kinda Najem, and Edward A. Margolin
American Journal of Ophthalmology, 2017, Volume 177, Page 175
[10]
Donald J. DeGracia
Wiley Interdisciplinary Reviews: RNA, 2017, Volume 8, Number 4, Page e1415
[11]
Chin-Yi Cheng and Yu-Chen Lee
Evidence-Based Complementary and Alternative Medicine, 2016, Volume 2016, Page 1
[12]
Edward Lewis Tobinick
CNS Drugs, 2016, Volume 30, Number 6, Page 469
[13]
Wei Li, Nijasri C. Suwanwela, and Suthiluk Patumraj
Microvascular Research, 2016, Volume 106, Page 117
[14]
Deqing Xiong, Yuanyuan Deng, Bin Huang, Caixia Yin, Bo Liu, Jingshan Shi, and Qihai Gong
International Immunopharmacology, 2016, Volume 30, Page 157
[16]
A. A. Astakhova, D. V. Chistyakov, E. V. Pankevich, and M. G. Sergeeva
Biochemistry (Moscow), 2015, Volume 80, Number 10, Page 1262
[17]
Stefano de Franciscis, Luca Gallelli, Bruno Amato, Lucia Butrico, Alessio Rossi, Gianluca Buffone, Francesco G Caliò, Giovanni De Caridi, Raffaele Grande, and Raffaele Serra
International Wound Journal, 2016, Volume 13, Number 6, Page 1237
[18]
Jacqueline S. Laures-Gore and Tony W. Buchanan
Journal of Clinical and Experimental Neuropsychology, 2015, Volume 37, Number 7, Page 688
[19]
[20]
Stefano de Franciscis, Giovanni De Caridi, Mafalda Massara, Francesco Spinelli, Luca Gallelli, Gianluca Buffone, Francesco G Caliò, Lucia Butrico, Raffaele Grande, and Raffaele Serra
International Wound Journal, 2016, Volume 13, Number 5, Page 854
[21]
[22]
Raffaele Serra, Giorgio Volpentesta, Luca Gallelli, Raffaele Grande, Gianluca Buffone, Angelo Lavano, and Stefano de Franciscis
British Journal of Neurosurgery, 2014, Page 1
[23]
Derrick D. Rowe, Lisa A. Collier, Hilary A. Seifert, Cortney B. Chapman, Christopher C. Leonardo, Alison E. Willing, and Keith R. Pennypacker
European Journal of Neuroscience, 2014, Volume 40, Number 7, Page 3111
[24]
Tracey A. Ignatowski, Robert N. Spengler, Krishnan M. Dhandapani, Hedy Folkersma, Roger F. Butterworth, and Edward Tobinick
CNS Drugs, 2014, Volume 28, Number 8, Page 679

Comments (0)

Please log in or register to comment.
Log in